Sort
51,570 grants matching “autoimmune disease”
Role of the Intestinal Microbiota in ALS
$690,184Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2022 · NS
Role of the Intestinal Microbiota in ALS
$690,184Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2023 · NS
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice
$690,022Martin D Burke · University Of Illinois At Urbana-Champaign · R01 · FY2020 · HL
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
$689,934Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Diversity of TFH cells and DSA generation after kidney transplantation
$689,885Diana M Metes · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
ANTIGEN PRESENTATION IN HUMAN AUTOIMMUNE DISEASES
$689,881Dana-Farber Cancer Institute · P01 · FY2002 · AI
Controlling the flux of sphingosine-1-phosphate in vivo
$689,812Kevin R Lynch · University Of Virginia · R01 · FY2020 · AI
Insights into immune-related disease born from population genomics
$689,771Peter R Parham · Stanford University · U01 · FY2015 · AI
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors
$689,648Frederick Albert Matsen · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors
$689,648Frederick Albert Matsen · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Type 1 Diabetes TrialNet Clinical Center: Effects of Alefacept in New Onset T1D
$689,584Jennifer B Marks · University Of Miami School Of Medicine · U01 · FY2012 · DK
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
$689,571Li Zhou · Brigham And Women'S Hospital · R01 · FY2019 · AI
Viral infections and celiac disease pathogenesis
$689,470Bana Jabri · University Of Chicago · R01 · FY2014 · DK
Controlling the flux of sphingosine-1-phosphate in vivo
$689,462Kevin R Lynch · University Of Virginia · R01 · FY2023 · AI
Controlling the flux of sphingosine-1-phosphate in vivo
$689,462Kevin R Lynch · University Of Virginia · R01 · FY2022 · AI
Controlling the flux of sphingosine-1-phosphate in vivo
$689,462Kevin R Lynch · University Of Virginia · R01 · FY2021 · AI
Mechanism of cDC2 subset differentiation in peripheral organs
$689,382Yosuke Kumamoto · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Type 1 Diabetes TrialNet at Indiana University Clinical Center
$689,367Linda A Dimeglio · Indiana University Indianapolis · U01 · FY2011 · DK
The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes
$689,210Thomas Delong · University Of Colorado Denver · U01 · FY2025 · DK
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus
$689,149Bruce Alan Sullenger · Duke University · R01 · FY2018 · AR
Identifying and modulating pathologic T cells that govern oral mucosal immune related adverse events from immune checkpoint blockade
$689,062Rajan P. Kulkarni · Oregon Health & Science University · R01 · FY2025 · DE
Rhesus HHV-8 homologue in AIDS-related malignancies
$689,049Scott W Wong · Oregon Health & Science University · R01 · FY2012 · CA
Acquisition of high-parameter fluorescent-activated cell sorter analyzer
$689,031Betty Diamond · Feinstein Institute For Medical Research · S10 · FY2025 · OD
Checkpoints and Autoimmune Homeostasis in T1D
$689,022Gerald T Nepom · University Of Colorado Denver · U19 · FY2008 · AI
Sex, sex steroids and dry eye syndromes
$688,977David A Sullivan · Schepens Eye Research Institute · R01 · FY2010 · EY